Ali I. Gardezi

ORCID: 0000-0003-1831-860X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Central Venous Catheters and Hemodialysis
  • Dialysis and Renal Disease Management
  • Vascular Procedures and Complications
  • Renal Transplantation Outcomes and Treatments
  • Organ Donation and Transplantation
  • Peripheral Artery Disease Management
  • Renal and Vascular Pathologies
  • Vascular anomalies and interventions
  • Liver Disease Diagnosis and Treatment
  • Cerebrovascular and Carotid Artery Diseases
  • Parathyroid Disorders and Treatments
  • Complement system in diseases
  • Hepatitis C virus research
  • Medical Imaging and Pathology Studies
  • Liver Disease and Transplantation
  • COVID-19 and healthcare impacts
  • Vascular Malformations Diagnosis and Treatment
  • Renal Diseases and Glomerulopathies
  • Genetic and Kidney Cyst Diseases
  • Neurological Complications and Syndromes
  • Hallucinations in medical conditions
  • Rheumatoid Arthritis Research and Therapies
  • Cardiovascular Syncope and Autonomic Disorders
  • Anesthesia and Sedative Agents
  • Muscle and Compartmental Disorders

Sygehus Sønderjylland
2025

University of Southern Denmark
2025

University of Wisconsin–Madison
2016-2024

University of Wisconsin System
2021

UW Health University Hospital
2020

Royal Gwent Hospital
2016

Baylor College of Medicine
2000

Background: In multiple sclerosis (MS), the educational gradient in diagnostic and disease-modifying treatment (DMT) delays is sparsely examined, results are mixed. Objectives: Among patients with relapsing-remitting MS (RRMS), we aimed to examine delay initiation of first DMT. Design: A nationwide cohort study. Methods: We linked Danish Multiple Sclerosis Registry other registries. Diagnostic was evaluated 4344 ⩾20 years at clinical onset from January 1, 2012, onwards, diagnosed by March...

10.1177/17562864251313918 article EN cc-by-nc Therapeutic Advances in Neurological Disorders 2025-01-01

Abstract Background Treatment of end-stage kidney disease (ESKD) with hemodialysis requires surgical creation an arteriovenous (AV) vascular access—fistula (AVF) or graft (AVG)—to avoid (or limit) the use a central venous catheter (CVC). AVFs have long been considered first-line access option, AVGs as second best. Recent studies suggested that, in older adults, may be better strategy than AVFs. Lacking evidence from well-powered randomized clinical trials, integration these results into...

10.1186/s12882-023-03086-5 article EN cc-by BMC Nephrology 2023-02-24

A mega fistula can be defined as generalized aneurysmal dilatation of arteriovenous fistula. Mega fistulae lead to complications like high output cardiac failure, steal syndrome, skin ulceration and rupture. We describe a series ten patients who were referred our interventional nephrology practice for evaluation which had not been in use long time. Nine out post-transplant while one was pre dialysis. Five Radiocephalic four Brachiocephalic Brachial artery Median Cubital vein All except...

10.1177/1129729820968425 article EN The Journal of Vascular Access 2020-10-26

Peritoneal dialysis (PD) has been used increasingly in past decade. Many of these patients undergo transplantation and may require for delayed graft function (DGF). The outcomes DGF based on the post-transplantation modality are not well known.

10.1016/j.ekir.2021.03.899 article EN cc-by-nc-nd Kidney International Reports 2021-04-19

Place and duration of study: The study was conducted at diabetic clinic B.V. Hospital/Q.A.M.C Bahawalpur from December 1st, 2004 to March 15th, 2005. Background: Diabetes mellitus hepatitis C infections are common emerging problems the society. Either diabetes is in chronic patients as reported initially by Ellison co-workers or infection more frequent mellitus. We want frequency c Objectives: To note any risk factors predisposing infection. Designs: A...

10.21649/akemu.v11i4.1109 article EN cc-by Annals of King Edward Medical University 2016-04-30

Vascular access dysfunction is a major cause of morbidity in patients with end-stage renal disease (ESRD) on chronic hemodialysis. The effects abnormalities mineral metabolism vascular are unclear. In this study, we evaluated the association metabolites, including 25-hydroxy vitamin D (25(OH)D) and fibroblast growth factor-23 (FGF-23), complications.We included participants from Choices for Healthy Outcomes Caring ESRD (CHOICE) Study who were using an arteriovenous fistula (AVF; n = 103) or...

10.1111/hdi.12798 article EN Hemodialysis International 2019-12-01

Background: The effects of delayed graft function on long-term kidney allograft outcomes are poorly defined among simultaneous liver and transplant recipients. Methods: We analyzed data all recipients transplanted at the University Wisconsin between 2010 2017. Risk factors for development function, failure, patient mortality were interest. Results: There a total 60 recipients; 28 (47%) had function. After adjustment multiple variables, we found that pretransplant dialysis >6 weeks (hazard...

10.1177/1526924820958155 article EN Progress in Transplantation 2020-09-15

Introduction: The Center for Medicare and Medicaid Services introduced an End-Stage Renal Disease Prospective Payment System (PPS) in 2011 to increase the utilization of home dialysis modalities, including peritoneal (PD). Several studies have shown a significant PD after PPS implementation. However, its impact on patients with kidney allograft failure remains unknown. Methods: We conducted interrupted time series analysis using data from US Data (USRDS) that include all adult transplant...

10.1159/000539062 article EN American Journal of Nephrology 2024-05-16

This article presents the rationale, challenges, and adaptive strategies employed during initiation execution of AV Access trial—a multicenter randomized controlled trial (RCT) comparing arteriovenous fistulas (AVFs) grafts (AVGs) for hemodialysis in older adults with major comorbidities. Motivated by shifts epidemiologic landscapes evolving guidelines moving away from a Fistula First approach to more patient-centric approaches, objective this RCT is fill critical knowledge gaps determining...

10.1016/j.jvsvi.2024.100108 article EN cc-by-nc-nd JVS-Vascular Insights 2024-01-01

Background: Delay in care of suspected stenosis or thrombosis can increase the chance losing a functioning hemodialysis access. Access to and resources were restricted during COVID-19 pandemic. To evaluate impact pandemic on arteriovenous fistula (AVF) graft (AVG) procedures we have assessed number success thrombectomies done before Methods: We examined all AVF AVG angiograms with without interventions, including thrombectomies, performed at single center April 2017–March 2021 (pre-COVID-19...

10.1177/11297298221116236 article EN The Journal of Vascular Access 2022-08-11

<h3>Introduction</h3> Mortality related to end-stage liver disease is increasing. Coupled with an ageing population, this will lead increasing numbers of those aged over 65 a de novo diagnosis cirrhosis. However, the incidence and clinical behaviour cirrhosis in old age not well understood. Our aim was evaluate elucidate characteristics elderly patients. <h3>Methods</h3> All patients at our institution were identified using health board electronic record. Data on patient demographics, date...

10.1136/gutjnl-2016-312388.173 article EN Gut 2016-06-01

Gardezi, Ali I.; Yuan, Zhongyu; Aziz, Fahad; Parajuli, Sandesh; Mandelbrot, Didier A.; Chan, Micah R.; Astor, Brad C. Author Information

10.1681/asn.20233411s1911b article EN Journal of the American Society of Nephrology 2023-11-01

Journal of the American Society Nephrology 34(11S):p 328, November 2023. | DOI: 10.1681/ASN.20233411S1328c

10.1681/asn.20233411s1328c article EN Journal of the American Society of Nephrology 2023-11-01
Coming Soon ...